MerLion announces FDA approval of finafloxacin otic suspension
Singapore, 11 February 2015 – MerLion Pharmaceuticals (MerLion), a biopharmaceutical company
headquartered in Singapore with clinical development operations in Berlin, Germany, today announced
that an otic
- 11 02 2015
- |